Literature DB >> 11533302

Glutamine and the bowel.

P J Reeds1, D G Burrin.   

Abstract

Since the pioneering work of Windmueller and Spaeth, the importance of glutamine to the support of intestinal mucosal metabolic function has become generally accepted. Nevertheless, the mechanisms underlying this role still remain obscure. This paper explores a number of questions: 1) Is glutamine essential for intestinal function? 2) To what extent does this relate to its intermediary metabolism? 3) What is the importance of glutamine as a biosynthetic precursor? 4) Is glutamine supplementation of the nutrient mixture presented to patients of any metabolic or clinical benefit? As a result of this exploratory exercise, the following general conclusions were reached: 1) Much suggestive biochemical and physiologic evidence exists that implies that glutamine, especially systemic glutamine, supports the function of the intestinal mucosal system. 2) Despite the extensive metabolism of this amino acid by the intestinal tissues, most evidence suggests that if glutamine does play a physiologic role in the bowel, it is not compellingly related to its intermediary metabolism. 3) There is, on the other hand, evidence that the mucosal cells not only utilize extracellular glutamine but synthesize the amino acid. Given that inhibition of glutamine synthesis inhibits both proliferation and differentiation of mucosal cell cultures, this suggests some more subtle regulatory role. This notion is supported by the demonstration that glutamine will activate a number of genes associated with cell cycle progression in the mucosa. 4) Despite the accumulated evidence, the mechanisms underlying glutamine's function and the question whether glutamine supplementation uniformly benefits mucosal health remain equivocal at best.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533302     DOI: 10.1093/jn/131.9.2505S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  34 in total

1.  Reduced stress tolerance of glutamine-deprived human monocytic cells is associated with selective down-regulation of Hsp70 by decreased mRNA stability.

Authors:  Maja Munk Eliasen; Marianne Brabec; Christopher Gerner; Jürgen Pollheimer; Herbert Auer; Maria Zellner; Gertrude Weingartmann; Fritz Garo; Erich Roth; Rudolf Oehler
Journal:  J Mol Med (Berl)       Date:  2005-11-25       Impact factor: 4.599

2.  GABA selectively increases mucin-1 expression in isolated pig jejunum.

Authors:  Jörg R Aschenbach; Carolin Deiner; Hannah-Sophie Braun; Gerhard Sponder; Robert Pieper
Journal:  Genes Nutr       Date:  2015-10-15       Impact factor: 5.523

3.  Effect of oral glutamine administration on bacterial tanslocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice.

Authors:  Vassilios G Margaritis; Kriton S Filos; Marina A Michalaki; Chrisoula D Scopa; Iris Spiliopoulou; Vassiliki N Nikolopoulou; Constantine E Vagianos
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

4.  Epidermal growth factor receptor expression and signaling are essential in glutamine's cytoprotective mechanism in heat-stressed intestinal epithelial-6 cells.

Authors:  Stefanie Niederlechner; Christine Baird; Benjamin Petrie; Erhard Wischmeyer; Paul E Wischmeyer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-28       Impact factor: 4.052

5.  In human entrocytes, GLN transport and ASCT2 surface expression induced by short-term EGF are MAPK, PI3K, and Rho-dependent.

Authors:  Nelly E Avissar; Harry C Sax; Liana Toia
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

6.  Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.

Authors:  Jerry R Greenfield; I Sadaf Farooqi; Julia M Keogh; Elana Henning; Abdella M Habib; Anthea Blackwood; Frank Reimann; Jens J Holst; Fiona M Gribble
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

7.  Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.

Authors:  Raphael S Rodrigues; Renato A C Oliveira; Yuesheng Li; Snjezana Zaja-Milatovic; Lourrany B Costa; Manuel B Braga Neto; Glynis L Kolling; Aldo A Lima; Richard L Guerrant; Cirle Alcantara Warren
Journal:  J Infect Dis       Date:  2013-01-28       Impact factor: 5.226

8.  Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism.

Authors:  M Andrea Azcarate-Peril; Eric Altermann; Yong Jun Goh; Richard Tallon; Rosemary B Sanozky-Dawes; Erika A Pfeiler; Sarah O'Flaherty; B Logan Buck; Alleson Dobson; Tri Duong; Michael J Miller; Rodolphe Barrangou; Todd R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

9.  Inflammation and foveolar hyperplasia are reduced by supplemental dietary glutamine during Helicobacter pylori infection in mice.

Authors:  Susan J Hagen; Masa Ohtani; Jin-Rong Zhou; Nancy S Taylor; Barry H Rickman; George L Blackburn; James G Fox
Journal:  J Nutr       Date:  2009-03-04       Impact factor: 4.798

10.  Glutamine supplementation attenuates ethanol-induced disruption of apical junctional complexes in colonic epithelium and ameliorates gut barrier dysfunction and fatty liver in mice.

Authors:  Kamaljit K Chaudhry; Pradeep K Shukla; Hina Mir; Bhargavi Manda; Ruchika Gangwar; Nikki Yadav; Megan McMullen; Laura E Nagy; RadhaKrishna Rao
Journal:  J Nutr Biochem       Date:  2015-08-20       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.